Stephen Machatha - Net Worth and Insider Trading
Stephen Machatha Net Worth
The estimated net worth of Stephen Machatha is at least $1 Million dollars as of 2024-12-27. Stephen Machatha is the Chief Development Officer of Aldeyra Therapeutics Inc and owns about 236,771 shares of Aldeyra Therapeutics Inc (ALDX) stock worth over $1 Million. Details can be seen in Stephen Machatha's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stephen Machatha has not made any transactions after 2024-08-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Stephen Machatha
Stephen Machatha Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stephen Machatha owns 1 companies in total, including Aldeyra Therapeutics Inc (ALDX) .
Click here to see the complete history of Stephen Machatha’s form 4 insider trades.
Insider Ownership Summary of Stephen Machatha
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALDX | Aldeyra Therapeutics Inc | 2024-08-12 | Chief Development Officer |
Stephen Machatha Latest Holdings Summary
Stephen Machatha currently owns a total of 1 stock. Stephen Machatha owns 236,771 shares of Aldeyra Therapeutics Inc (ALDX) as of August 12, 2024, with a value of $1 Million.
Latest Holdings of Stephen Machatha
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALDX | Aldeyra Therapeutics Inc | 2024-08-12 | 236,771 | 5.02 | 1,188,590 |
Holding Weightings of Stephen Machatha
Stephen Machatha Form 4 Trading Tracker
According to the SEC Form 4 filings, Stephen Machatha has made a total of 3 transactions in Aldeyra Therapeutics Inc (ALDX) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Aldeyra Therapeutics Inc is the sale of 16,041 shares on August 12, 2024, which brought Stephen Machatha around $76,034.
Insider Trading History of Stephen Machatha
- 1
Stephen Machatha Trading Performance
Stephen Machatha Ownership Network
Stephen Machatha Owned Company Details
What does Aldeyra Therapeutics Inc do?
Who are the key executives at Aldeyra Therapeutics Inc?
Stephen Machatha is the Chief Development Officer of Aldeyra Therapeutics Inc. Other key executives at Aldeyra Therapeutics Inc include See Remarks Bruce Greenberg , 10 percent owner Perceptive Life Sciences Master Fund Ltd , and director & President and CEO Todd C Brady .
Aldeyra Therapeutics Inc (ALDX) Insider Trades Summary
Over the past 18 months, Stephen Machatha made 3 insider transaction in Aldeyra Therapeutics Inc (ALDX) with a net sale of 57,346. Other recent insider transactions involving Aldeyra Therapeutics Inc (ALDX) include a net sale of 2,074,234 shares made by Perceptive Life Sciences Master Fund Ltd , a net sale of 37,236 shares made by Bruce Greenberg , and a net sale of 183,238 shares made by Todd C Brady .
In summary, during the past 3 months, insiders sold 0 shares of Aldeyra Therapeutics Inc (ALDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,034,319 shares of Aldeyra Therapeutics Inc (ALDX) were sold and 682,265 shares were bought by its insiders, resulting in a net sale of 2,352,054 shares.
Aldeyra Therapeutics Inc (ALDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aldeyra Therapeutics Inc Insider Transactions
Stephen Machatha Mailing Address
Above is the net worth, insider trading, and ownership report for Stephen Machatha. You might contact Stephen Machatha via mailing address: 131 Hartwell Avenue, Suite 320, Lexington Ma 02421.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
